IKZF4 and neoplasm: However, the associations of the OS, DSS, and PFI rates of patients with higher expression levels of IKZF4–5 were not significantly different (Figures 5D,E), and patients who expressed high levels of IKZF1–3 experienced significantly longer DSS and longer tumor progression-free survival.